#1
Posted: Thu Mar 05, 2026 10:53 pm
For patients with asthma, receipt of immune checkpoint inhibitor (ICI) therapy for melanoma or renal cell carcinoma is not associated with an increased risk for exacerbations, according to a study presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology, held from Feb. 27 to March 2 in Philadelphia.
Source: https://medicalxpress.com/news/2026-03- ... anoma.html
Source: https://medicalxpress.com/news/2026-03- ... anoma.html